Editorial Staff

  • Executive Editor/VP-Special Projects:
    Jeff Hall
  • Senior Editor
    Brian McCurdy
  • Circulation and Subscriptions
    Bonnie Shannon
  • Art Director:
    Alana Balboni
  • Editorial Correspondence

  • Jeff Hall, Executive Editor/VP-Special Projects, Podiatry Today
  • HMP Communications, 83 General Warren Blvd
    Suite 100, Malvern PA 19355
  • Telephone: (800) 237-7285, ext. 214
    Fax: (610) 560-0501
  • Email: jhall@hmpcommunications.com
  • December 2002 | Volume 15 - Issue 12
    Have you ever encountered a medical acronym but found its meaning is on the tip of your tongue? The site www.pharma-lexicon.com can shed some light on the subject. The Web site offers a database of over 56,000 medical, pharmaceutical, biotech and agrochem
    By Brian McCurdy, Associate Editor
    7,016 reads | 0 comments | 09/03/08
    In the wake of increasing threats of resistant bacteria strains such as MRSA, new data presented at the 40th Annual Meeting of the Infectious Diseases Society of America provides some hope. Researchers revealed that linezolid may have promise in treating diabetic foot infections caused by bacteria such as Staphylococcus aureus. According to the results of the study, which involved over 350 patients at U.S. and European sites, 81.3 percent of the linezolid patients were “clinically cured,” compared to 71.3 percent of patients who received a standard aminopenicillin combination. Be... continue reading
    Here is a clinical view of Charcot’s arthropathy of the left lower extremity.
    By Guy R. Pupp, DPM, David T. Savage, DPM, MS, and Mark B. Hellmann, DPM, MS
    21,807 reads | 0 comments | 09/03/08
    Neuropathic osteoarthropathy is a debilitating condition that affects diabetic patients with peripheral neuropathy. This distinct pathologic entity, commonly known as Charcot’s arthropathy or Charcot’s joint disease, is characterized by pathologic fractures, joint dislocation and deformity, resulting in a foot at high risk for ulceration and amputation in severe cases. Armstrong, et. al., found the prevalence of Charcot’s arthropathy ranges between 0.16 percent in the general diabetic population of patients to 13 percent of patients presenting to a high-risk diabetic foot clinic.1<... continue reading